• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4643503)   Today's Articles (315)   Subscriber (50552)
For: Takaori M. Approach to Clinical Trial Considering Medical Ethics and Efficacy for HbV, Liposome Encapsulated Hemoglobin Vesicle. ACTA ACUST UNITED AC 2009;33:65-73. [PMID: 15768566 DOI: 10.1081/bio-200046695] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Number Cited by Other Article(s)
1
Taguchi K, Maruyama T, Otagiri M. Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells. Drug Metab Rev 2011;43:362-73. [DOI: 10.3109/03602532.2011.558094] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
2
Agashe H, Awasthi V. Chapter 1 Current Perspectives in Liposome‐Encapsulated Hemoglobin as Oxygen Carrier. ADVANCES IN PLANAR LIPID BILAYERS AND LIPOSOMES 2009. [DOI: 10.1016/s1554-4516(09)09001-2] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
3
Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm Res 2006;23:1417-50. [PMID: 16779701 DOI: 10.1007/s11095-006-0284-8] [Citation(s) in RCA: 517] [Impact Index Per Article: 28.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2005] [Accepted: 03/01/2006] [Indexed: 01/19/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA